Advances in Aβ imaging probes: a comprehensive study of radiolabelled 1,3-diaryl-2-propen-1-ones for Alzheimer's disease: a review
Sudeep Dhillon, Mayank Kinger, Priyanka Rani, Mamta Chahal, Ginna Kumari, Deepak Kumar Aneja, Sang Wook Kim, Eunseok Choi, Sushil Kumar · 2023
Read Advances in Aβ imaging probes: a comprehensive study of radiolabelled 1,3-diaryl-2-propen-1-ones for Alzheimer's disease: a review by Sudeep Dhillon, Mayank Kinger, Priyanka Rani, Mamta Chahal, Ginna Kumari, Deepak Kumar Aneja, Sang Wook Kim, Eunseok Choi, Sushil Kumar (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10712011.txt.
Description
Sudeep Dhillon and co-authors review a family of glowing tracer compounds meant to image amyloid plaques in Alzheimer's disease. The compounds, called chalcones, can be tagged with radioactive labels and read by PET or SPECT scanners, which could flag the disease early. The review covers how these molecules are made, what they do in the body, and how they serve as starting points for natural product chemistry.
The authors walk through the main tracers in use, from fluorinated sugars to carbon-11 and iodine labeled agents, and weigh their worth for diagnosis. They also discuss the compounds' possible roles beyond imaging, in drug development and treatment. The review frames chalcone tracers as a meeting point of chemistry and brain imaging, with early detection as the prize.
Catalog record
| CREATOR | Sudeep Dhillon, Mayank Kinger, Priyanka Rani, Mamta Chahal, Ginna Kumari, Deepak Kumar Aneja, Sang Wook Kim, Eunseok Choi, Sushil Kumar |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 101 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |